Psychosis News and Research RSS Feed - Psychosis News and Research

Psychosis means abnormal condition of the mind, and is a generic psychiatric term for a mental state often described as involving a "loss of contact with reality". People suffering from psychosis are said to be ''psychotic.''
Findings point to biological mechanisms and pathways that may underlie schizophrenia

Findings point to biological mechanisms and pathways that may underlie schizophrenia

As part of a multinational, collaborative effort, researchers from the University of North Carolina School of Medicine and scores of other institutions from all over the world have helped identify over 100 locations in the human genome associated with the risk of developing schizophrenia, in what is the largest genomic study published on any psychiatric disorder to date. [More]
Symptom remission main predictor of functional outcomes in psychosis

Symptom remission main predictor of functional outcomes in psychosis

Remission of positive and negative symptoms is the most important predictor of functional outcomes among patients with first-episode psychosis, with cognition having only a small impact, say researchers. [More]
Motivational impairment could be early target for psychosis risk

Motivational impairment could be early target for psychosis risk

Research suggests that motivational impairment may be present before psychosis onset but does not worsen over the course of the illness. [More]
Very-late-onset schizophrenia linked to particularly high mortality risk

Very-late-onset schizophrenia linked to particularly high mortality risk

Patients with very-late-onset schizophrenia-like psychosis have an increased risk of death compared with both the general population and patients with schizophrenia diagnosed earlier in life, Finnish study findings indicate. [More]
Sleep problems in PD patients can worsen in later stages of disease

Sleep problems in PD patients can worsen in later stages of disease

Up to 70% of Parkinson's disease (PD) patients experience sleep problems that negatively impact their quality of life. [More]
Sleep deprivation can lead a healthy person to display symptoms similar to schizophrenia

Sleep deprivation can lead a healthy person to display symptoms similar to schizophrenia

Twenty-four hours of sleep deprivation can lead to conditions in healthy persons similar to the symptoms of schizophrenia. This discovery was made by an international team of researchers under the guidance of the University of Bonn and King's College London. [More]
Insight has ‘trait-like properties’ in psychosis

Insight has ‘trait-like properties’ in psychosis

Poor insight persists in many patients after their first episode of psychosis and is predicted by insight at baseline, report researchers. [More]
Neuroimaging support for psychosis continuum

Neuroimaging support for psychosis continuum

Cortical thinning is present in people with nonclinical psychotic symptoms, but is less pronounced than in those with a psychotic disorder, report researchers [More]
LBDA offers condolences over death of LBD patient

LBDA offers condolences over death of LBD patient

The sad news of Casey Kasem's illness and passing has brought unexpected visibility to a disease unfamiliar to many people. [More]
Moving during childhood linked to increased schizophrenia risk

Moving during childhood linked to increased schizophrenia risk

Childhood residential mobility is associated with an increased risk of psychotic disorders, particularly schizophrenia, during adulthood, according to results of a study conducted in Denmark. [More]
Cogstate announces signing of first contract for Precision Recruitment tool

Cogstate announces signing of first contract for Precision Recruitment tool

Cognition technology company Cogstate is pleased to announce the signing of its first contract for Precision Recruitment, a new web-based tool for streamlining patient recruitment for clinical drug trials. [More]
Brain structure linked to psychosis symptoms

Brain structure linked to psychosis symptoms

A study of patients across the psychosis spectrum supports an association between brain structure and psychosis symptoms. [More]
Studies show relation between spice and different types of psychosis

Studies show relation between spice and different types of psychosis

Professors of Medicine Degree at the CEU Cardenal Herrera University and the Provincial Hospital of Castellón, in collaboration with doctors of the Addictive Behaviors Unit of Valencia, have described the first case of catatonic psychosis caused by a synthetic derivate of Cannabis: the spice. [More]

Study offers clues to best long-acting injectable antipsychotic use

Findings from the PROACTIVE study suggest why the benefits of long-acting injectable second-generation antipsychotics may be difficult to detect in a clinical trial. [More]
EC approves extension of INVEGA antipsychotic drug to include adolescents aged 15 years and older

EC approves extension of INVEGA antipsychotic drug to include adolescents aged 15 years and older

Janssen-Cilag International NV announced today that the European Commission has approved an extension of the oral atypical antipsychotic INVEGA® (paliperidone ER) schizophrenia indication, to include adolescents aged 15 years and older. [More]
Tackling ambivalence helps psychosis patients back into work

Tackling ambivalence helps psychosis patients back into work

Teaching motivational interviewing to clinicians providing vocational rehabilitation through individual placement and support improves occupational outcomes for young people with early psychosis, UK researchers report. [More]
Drug use linked to persistent violence in psychosis patients

Drug use linked to persistent violence in psychosis patients

Patients with first-episode psychosis are more likely to report being involved in violence over subsequent years if they persist with illicit drug use, a 10-year study shows. [More]

Hippocampal role in psychosis bolstered

Reduced hippocampal volumes exist in patients across the psychosis spectrum, shows the latest report from the B-SNIP study. [More]
Mylan releases generic version of Zyprexa Zydis Tablets

Mylan releases generic version of Zyprexa Zydis Tablets

Mylan Inc. today announced that it has launched Olanzapine Orally Disintegrating Tablets (ODT), 5 mg, 10 mg, 15 mg and 20 mg, the generic version of Eli Lilly and Company's Zyprexa Zydis Tablets. [More]
Genetic changes linked to altered default mode network in psychosis

Genetic changes linked to altered default mode network in psychosis

Researchers have identified biological processes likely to underlie altered activity in the resting-state default mode network in patients with psychosis. [More]